|
JP3626996B2
(ja)
|
1992-05-23 |
2005-03-09 |
グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム |
Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
|
|
US6355450B1
(en)
|
1995-04-21 |
2002-03-12 |
Human Genome Sciences, Inc. |
Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
|
|
US6468765B1
(en)
|
1995-04-21 |
2002-10-22 |
Human Genome Sciences, Inc. |
Selected Haemophilus influenzae Rd polynucleotides and polypeptides
|
|
US6696065B1
(en)
|
1995-05-04 |
2004-02-24 |
Aventis Pastuer Limited |
Acellular pertussis vaccines and methods of preparation thereof
|
|
EP0833662B2
(en)
*
|
1995-06-23 |
2011-01-26 |
SmithKline Beecham Biologicals S.A. |
A vaccine composition comprsing a Haemophilus influenzae B polysaccharide conjugate antigen adsorbed onto aluminium phosphate
|
|
AU714493B2
(en)
*
|
1996-07-02 |
2000-01-06 |
Connaught Laboratories Limited |
Multivalent DTP-polio vaccines
|
|
GB9806456D0
(en)
*
|
1998-03-25 |
1998-05-27 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
ES2284287T3
(es)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
US6585973B1
(en)
*
|
1998-10-29 |
2003-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method for preparing solid phase conjugated vaccine
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
GB0108364D0
(en)
|
2001-04-03 |
2001-05-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
EP1946769B1
(en)
*
|
2000-06-29 |
2012-05-30 |
SmithKline Beecham Biologicals S.A. |
Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
|
|
CA2435681C
(en)
|
2001-01-23 |
2011-06-21 |
Aventis Pasteur |
Multivalent meningococcal polysaccharide-protein conjugate vaccine
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
EP2351579B1
(en)
|
2002-10-11 |
2016-09-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
|
|
CA2503871C
(en)
|
2002-11-01 |
2012-12-11 |
Glaxosmithkline Biologicals S.A. |
An immunogenic composition for generating an immune response against polio virus
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
DK1587537T3
(da)
|
2003-01-30 |
2012-07-16 |
Novartis Ag |
Injicerbare vacciner mod multiple meningococ-serogrupper
|
|
GB0313916D0
(en)
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
ES2397923T3
(es)
|
2003-10-02 |
2013-03-12 |
Novartis Ag |
Vacunas líquidas para múltiples serogrupos meningocócicos
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
AU2004277342B2
(en)
*
|
2003-10-02 |
2010-12-16 |
Glaxosmithkline Biologicals S.A. |
Pertussis antigens and use thereof in vaccination
|
|
GB0405787D0
(en)
|
2004-03-15 |
2004-04-21 |
Chiron Srl |
Low dose vaccines
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
RU2379052C2
(ru)
|
2004-04-30 |
2010-01-20 |
Чирон С.Р.Л. |
Вакцинация менингококковыми конъюгатами
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
GB0505518D0
(en)
|
2005-03-17 |
2005-04-27 |
Chiron Srl |
Combination vaccines with whole cell pertussis antigen
|
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
|
EP1871411A4
(en)
|
2005-04-18 |
2010-07-21 |
Novartis Vaccines & Diagnostic |
EXPRESSION OF HEPATITIS B VIRUS SURFACE ANTIGEN FOR VACCINE MANUFACTURE
|
|
HUE045482T2
(hu)
|
2005-06-27 |
2019-12-30 |
Glaxosmithkline Biologicals Sa |
Immunogén készítmény
|
|
GB0522765D0
(en)
|
2005-11-08 |
2005-12-14 |
Chiron Srl |
Combination vaccine manufacture
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
NZ572054A
(en)
|
2006-03-22 |
2011-12-22 |
Novartis Ag |
Regimens for immunisation with meningococcal conjugates
|
|
US10828361B2
(en)
|
2006-03-22 |
2020-11-10 |
Glaxosmithkline Biologicals Sa |
Regimens for immunisation with meningococcal conjugates
|
|
SI2097102T1
(sl)
|
2006-09-07 |
2012-09-28 |
Glaxosmithkline Biolog Sa |
Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
|
|
JP2010525035A
(ja)
|
2007-05-02 |
2010-07-22 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
IN2009KN04098A
(enExample)
|
2007-06-04 |
2015-08-28 |
Novartis Ag |
|
|
FR2918671B1
(fr)
*
|
2007-07-10 |
2010-10-15 |
Sanofi Pasteur |
Milieu de culture d'haemophilus influenzae type b.
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
GB0822633D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
|
TW201043267A
(en)
*
|
2009-03-19 |
2010-12-16 |
Intervet Int Bv |
In situ constituting a vaccine for administration to a predetermined herd of animals
|
|
CN104548082A
(zh)
*
|
2009-03-24 |
2015-04-29 |
诺华股份有限公司 |
为脑膜炎球菌因子h结合蛋白添加佐剂
|
|
IT1398927B1
(it)
|
2009-06-25 |
2013-03-28 |
Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi |
Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
US10092640B2
(en)
|
2011-01-05 |
2018-10-09 |
Bharat Biotech International Limited |
Combination heptavalent vaccine
|
|
GB201105981D0
(en)
|
2011-04-08 |
2011-05-18 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
TW201302779A
(zh)
|
2011-04-13 |
2013-01-16 |
Glaxosmithkline Biolog Sa |
融合蛋白質及組合疫苗
|
|
DE102011118371B4
(de)
|
2011-11-11 |
2014-02-13 |
Novartis Ag |
Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
|
|
EP2592137A1
(en)
|
2011-11-11 |
2013-05-15 |
Novartis AG |
Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
|
|
GB2495341B
(en)
|
2011-11-11 |
2013-09-18 |
Novartis Ag |
Fermentation methods and their products
|
|
DE102011122891B4
(de)
|
2011-11-11 |
2014-12-24 |
Novartis Ag |
Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
|
|
WO2013113729A1
(en)
|
2012-02-01 |
2013-08-08 |
Glaxosmithkline Biologicals S.A. |
Fermentation process
|
|
WO2014009971A2
(en)
*
|
2012-07-07 |
2014-01-16 |
Bharat Biotech International Limited |
Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
EP2906239A1
(en)
|
2012-10-12 |
2015-08-19 |
GlaxoSmithKline Biologicals SA |
Non-cross-linked acellular pertussis antigens for use in combination vaccines
|
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
|
US11219680B2
(en)
|
2017-02-24 |
2022-01-11 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
|
|
BR112020000999A2
(pt)
|
2017-07-18 |
2020-07-14 |
Serum Institute Of India Pvt Ltd. |
composição imunogênica tendo estabilidade aperfeiçoada, imunogenicidade melhorada e reatogenicidade reduzida e processo para a sua preparação
|
|
KR102822878B1
(ko)
|
2018-10-12 |
2025-06-20 |
세럼 인스티튜트 오브 인디아 프라이비트 리미티드 |
감소된 용량의 불활성화된 폴리오바이러스를 포함하는 조합 백신 조성물 및 그의 제조 방법
|
|
US11433129B2
(en)
|
2019-05-20 |
2022-09-06 |
Soligenix, Inc. |
Compositions and methods of manufacturing trivalent filovirus vaccines
|
|
CN111658617A
(zh)
*
|
2019-10-14 |
2020-09-15 |
四川大学 |
一种含铝佐剂疫苗的冻干制剂及其制备方法和用途
|